These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30805946)

  • 21. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
    Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
    Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.
    Bogen DL; Perel JM; Helsel JC; Hanusa BH; Thompson M; Wisner KL
    Breastfeed Med; 2011 Dec; 6(6):377-84. PubMed ID: 21348770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic Population Pharmacokinetics of Morphine in Neonates With Abstinence Syndrome After Oral Administration of Diluted Tincture of Opium.
    Liu T; Lewis T; Gauda E; Gobburu J; Ivaturi V
    J Clin Pharmacol; 2016 Aug; 56(8):1009-18. PubMed ID: 26712409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Breast feeding during methadon- and buprenorphin therapy].
    Müller MJ; Lange M; Paul T; Seeliger S
    Klin Padiatr; 2011 Dec; 223(7):408-13. PubMed ID: 21969026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
    Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
    Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.
    Tang F; Ng CM; Bada HS; Leggas M
    Clin Transl Sci; 2021 Jul; 14(4):1231-1249. PubMed ID: 33650314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
    Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
    J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective Analysis of Methadone and EDDP in Laboring Women and Neonates in Plasma and Dried Blood Spots and Association with Neonatal Abstinence Syndrome.
    Metzger IF; Thomas AE; Evrard CA; Jones DR; Masters AR; Haas DM; Haneline LS; Quinney SK
    Am J Perinatol; 2021 Jul; 38(9):968-975. PubMed ID: 32052397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.
    Brown MS; Hayes MJ; Thornton LM
    J Perinatol; 2015 Apr; 35(4):278-83. PubMed ID: 25357093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are infants exposed to methadone in utero at an increased risk for mortality?
    Kelly LE; Rieder MJ; Bridgman-Acker K; Lauwers A; Madadi P; Koren G
    J Popul Ther Clin Pharmacol; 2012; 19(2):e160-5. PubMed ID: 22580362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
    Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G
    Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher maternal doses of methadone does not increase neonatal abstinence syndrome.
    Pizarro D; Habli M; Grier M; Bombrys A; Sibai B; Livingston J
    J Subst Abuse Treat; 2011 Apr; 40(3):295-8. PubMed ID: 21255960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
    Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
    Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers.
    Crauwels HM; van Heeswijk RP; Vandevoorde A; Buelens A; Stevens M; Hoetelmans RM
    J Clin Pharmacol; 2014 Feb; 54(2):133-40. PubMed ID: 24203510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necrotizing enterocolitis and its association with the neonatal abstinence syndrome.
    Andrews L; Davies TH; Haas J; Loudin S; Heyward A; Werthammer J
    J Neonatal Perinatal Med; 2020; 13(1):81-85. PubMed ID: 32280068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
    Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
    Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone and perinatal outcomes: a prospective cohort study.
    Cleary BJ; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ
    Addiction; 2012 Aug; 107(8):1482-92. PubMed ID: 22340442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.